Saturday Rounds: Week of October 3–9, 2026

Evidence funds the next proof point. Weekly Biotech Signal Review · Completed reporting week: October 3–October 9, 2026 · Published October 10, 2026 Report at a glance: Vaxcyte turned a pivotal pneumococcal readout into $1 billion of base financing within days, Bristol Myers Squibb posted…